PANCE Blueprint Pulmonary (12%)

Respiratory syncytial virus infection (ReelDX)

REEL-DX-ENHANCED-PAID-MEMBERS-ONLY

RSV

Patient will present as → a 5-month old infant with a three-day history of a mild respiratory tract infection with serous nasal discharge, fever of 38.5 C, and decreased appetite. Physical exam reveals a tachypneic infant with audible wheezing and a respiratory rate of 65.  Nasal flaring, use of accessory musclessubcostal and intercostal retractions are noted. Expiratory wheezes and a cough are present.

To watch this and all of Joe-Gilboy PA-C's spectacular video lessons you must be a member. Members can log in here or join now.

RSV is the most common cause of lower respiratory tract infections in children worldwide. Virtually all children contract it by the age of three.

  • It's the leading cause of pneumonia and bronchiolitis in infants. It may play a major role in the pathogenesis of asthma bronchiolitis

Distinct symptoms of RSV bronchiolitis include:

  • Rhinorrhea
  • Wheezing and coughing can persist for several months
  • Low-grade fever
  • Nasal flaring and retractions
  • Nail Bed cyanosis

Nasopharyngeal secretions RSV antigen test

  • CXR can show diffuse infiltrates

Indications for hospitalization include moderate tachypnea with feeding difficulties, visible retractions, and oxygen desaturation

  • Supportive measures include albuterol via nebulizer, antipyretics and humidified oxygen
  • Steroids (controversial)
  • Symptoms resolve within five to seven days

Palivizumab (Synagis) prophylaxis

  • Infants born at ≤ 28 weeks 6 days gestational age and <12 months at the start of RSV season
  • Infants < 12 months of age with chronic lung disease (CLD) of prematurity
  • Infants ≤ 12 months of age with hemodynamically significant CHD
  • Infants and children < 24 months of age with CLD of prematurity necessitating medical therapy (eg, supplemental oxygen, bronchodilator, diuretic, or chronic steroid therapy) within 6 months prior to the beginning of RSV season

AAP also suggests that palivizumab prophylaxis may be considered in the following circumstances:

  • Infants < 12 months of age with congenital airway abnormality or neuromuscular disorder that decreases the ability to manage airway secretions
  • Infants < 12 months of age with cystic fibrosis with clinical evidence of CLD and/or nutritional compromise
  • Children < 24 months with cystic fibrosis with severe lung disease (previous hospitalization for pulmonary exacerbation in the first year of life or abnormalities on chest radiography or chest computed tomography that persist when stable) or weight for length less than the 10th percentile
  • Infants and children < 24 months who are profoundly immunocompromised
  • Infants and children < 24 months undergoing cardiac transplantation during RSV season

IM_NUR_RSV_v1.2_ RSV, or respiratory syncytial virus, is a viral infection that infects upper airway epithelial cells, leading to copious secretions, coughing, sneezing and wheezing in patients. It primarily affects infants and young children with peak incidence between 2 to 7 months of age. It affects more male than female infants; occurs less frequently in breastfed infants; and has a peak incidence during winter and spring. Most cases of bronchiolitis are caused by RSV.

Question 1
A 3 month-old male presents with a hoarse cough and thick purulent rhinorrhea for the past 2 days. The mother noted that yesterday he appeared to get worse and seemed to have increasing problems breathing and trouble feeding. Examination reveals a temperature of 100.2 degrees F and respiratory rate of 80/minute with nasal flaring and retractions. Lung examination reveals a prolonged expiratory phase with inspiratory rales. He is tachycardic. Pulse oximetry reveals oxygen saturation of 89%. Chest x-ray reveals hyperinflation with diffuse interstitial infiltrates. Which of the following is the most appropriate intervention?
A
antibiotics
Hint:
Antibiotics are utilized to treat bacterial, not viral, illnesses.
B
hospitalization
C
inhaled corticosteroids
Hint:
Inhaled glucocorticoids (budesonide, fluticasone, dexamethasone) have not been beneficial in reducing symptom duration or readmission rates
D
Racemic epinephrine
Hint:
Racemic epinephrine is not indicated in the treatment of bronchiolitis.
Question 1 Explanation: 
This infant most likely has bronchiolitis. While most cases are mild and can be treated at home, hospitalization is recommended for infants with hypoxia on room air, moderate tachypnea with feeding difficulties and marked respiratory distress with retractions. Additionally hospitalization is recommended for infants less than 2-3 months of age, a history of apnea or an underlying chronic cardiopulmonary disease.
Question 2
Which of the following is an indication for hospitalization in a patient who has acute bronchiolitis?
A
pulse oximetry of 94% on room air
Hint:
A pulse oximetry reading of 94% on room air is equivalent to a PaO2 of approximately 80 mm Hg which indicates the child is not in severe respiratory distress.
B
children between 4-6 months of age
Hint:
Children less than 2 months of age require hospitalization.
C
moderate tachypnea with feeding difficulties
D
hyperinflation and interstitial infiltrates on chest x-ray
Hint:
Hyperinflation and interstitial infiltrates on chest x-ray are frequently seen with acute bronchiolitis and by themselves are not an indication for hospitalization.
Question 2 Explanation: 
Indications for hospitalization include moderate tachypnea with feeding difficulties.
Question 3
A previously healthy 8-month-old boy is hospitalized for acute bronchiolitis. He has no known significant past medical or family history. On admission, he exhibits nasal flaring and retractions with a respiratory rate of 68, axillary temperature of 102.0 degrees F and O2 saturation of 86%. Which of the following medications is indicated?
A
Prednisolone
Hint:
Corticosteroids are not indicated for the treatment of previously healthy infants with bronchiolitis.
B
Oxygen
C
Ceftriaxone (Rocephin)
Hint:
Antibiotics are not indicated in the treatment of bronchiolitis unless there is a secondary bacterial infection.
D
Palivizumab (Synagis)
Hint:
Palivizumab is used only for prevention of RSV infection.
Question 3 Explanation: 
Oxygen is an important supportive therapy for hypoxemic infants with bronchiolitis. Bronchodilators would also be initiated in this patient.
There are 3 questions to complete.
List
Return
Shaded items are complete.
123
Return
Viral pneumonia (Prev Lesson)
(Next Lesson) Tuberculosis (ReelDx)
Back to PANCE Blueprint Pulmonary (12%)

NCCPA™ Content Blueprint

The Daily PANCE and PANRE

Get 60 days of PANCE and PANRE Multiple Choice Board Review Questions delivered daily to your inbox. It's 100% FREE and 100% Awesome!

You have Successfully Subscribed!